Andrea Necchi
University of Milan
Internal medicineUrologySurgeryOncologyClinical endpointCystectomyChemotherapyGerm cell tumorsCisplatinPembrolizumabBladder cancerSalvage therapyMetastatic Urothelial CarcinomaMuscle invasiveIn patientUrothelial carcinomaPhases of clinical researchCancer researchProportional hazards modelMedicine
Publications 546
#2Aaron Dahmen (USF: University of South Florida)H-Index: 1
Last. Antonio Augusto OrnellasH-Index: 16
view all 21 authors...
OBJECTIVES To identify incidence and risk factors for upstaging from cN1 to pN2/N3 at inguinal lymphadenectomy (ILND) for penile cancer (pSCC). Our secondary objective is to assess survival outcomes and associations for cN1 patients undergoing ILND. SUBJECTS/PATIENTS AND METHODS Patients with pT≥1cN1cM0 pSCC who underwent bilateral ILND and had complete data were identified in a multi-institutional international cohort from 8 referral centers in 7 countries diagnosed from 1980 to 2017. Upstaging...
#1Chiara Lonati (UniSR: Vita-Salute San Raffaele University)
#2Marco MoschiniH-Index: 27
Last. Andrea NecchiH-Index: 35
view all 5 authors...
PURPOSE OF REVIEW To provide a comprehensive overview of diagnosis, treatment, and screening for upper tract urothelial carcinoma (UTUC) among Lynch syndrome patients. RECENT FINDINGS Lynch syndrome is an autosomal dominant disorder resulting from the germline mutation in the mismatch repair (MMR) system. The Lynch syndrome predisposes to early onset of a broad spectrum of tumours, among which UTUC represents the third most frequent malignancy. Since up to 10% of UTUC can be attributed to Lynch ...
#1Alberto MartiniH-Index: 27
#2G.O. CirulliH-Index: 3
Last. John P. SfakianosH-Index: 26
view all 15 authors...
#1Filippo PederzoliH-Index: 13
#2Irene LocatelliH-Index: 7
Last. Dejan LazarevicH-Index: 24
view all 17 authors...
#1Giuseppe FallaraH-Index: 3
#2Marco BandiniH-Index: 24
Last. Zhe TianH-Index: 30
view all 18 authors...
#1Nicola FossatiH-Index: 36
#2Giovanni MotterleH-Index: 5
Last. Alessandro NiniH-Index: 13
view all 26 authors...
INTRODUCTION AND OBJECTIVE:Salvage lymph node dissection (SLND) is considered an experimental treatment for patients with nodal recurrence after radical prostatectomy (RP). However, most of them al...
#1Alberto MartiniH-Index: 27
#2Giuseppe FallaraH-Index: 3
Last. Alberto BrigantiH-Index: 96
view all 16 authors...
#1Philippe E. SpiessH-Index: 35
Last. Ethan SokolH-Index: 13
view all 12 authors...